Monographie - N-acetylcysteine - Stabilis 4.0

Ultimo aggiornamento :
28/04/2024

Antidoto

N-acetylcysteine

Iniezione

Aerosol

Collirio

Soluzione orale

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

Metodo di iniezione

Bibliografia

Pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acetadote	Nuova Zelanda, Stati Uniti d’America
Acetylcystein	Canada, Danimarca
Acetylcysteine	Gran Bretagna, Iran
Cilol	India
DBL acetylcysteine	Malaysia, Nuova Zelanda
Fluimucil	Colombia, Ecuador, Francia, Germania, Paesi Bassi, Polonia, Portogallo, Svizzera, Ungheria
Hidonac	Francia, Italia, Malaysia, Romania, Spagna
Mucare	India
Mucofrin	Italia
Mucomelt	India
Mucomix	India
Mucosys	India
Nacel	India
Parvolex	Canada, Gran Bretagna, Grecia

Bibliografia

Iniezione

Bibliografia : N-acetylcysteine

	Tipo	Pubblicazione
1759	Rivista	Servais H, Tulkens PM. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
2076	Rivista	Dribben WH, Porto SM, Jeffords BK. Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning. Ann Emerg Med 2003 ; 42: 9-13.
2141	Rivista	Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM. Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 2003 ; 51: 651-658.
2231	Rivista	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3012	Rivista	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3372	Rivista	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3385	Rivista	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3408	Rivista	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3766	Rivista	Forrest J.M, Hildgen P. Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels Pharmactuel 2014 ; 47, 3 : 161-165.
3824	Rivista	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3964	Rivista	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4319	Rivista	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Rivista	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4603	Rivista	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4639	Rivista	Friciu M, Monfort A, Dubé P-A, Leclair G. Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions. Can J Hosp Pharm 2021 2021;74(4):344-9
4727	Rivista	Primas N, Lano G, Brun D, Curti C, Sallée M, Sampol-Manos E, Lamy E, Bornet C, Burtey S, Vanelle P. Stability Study of Parenteral N-Acetylcysteine, and Chemical Inhibition of Its Dimerization Pharmaceuticals 2023 ;16,72

Mentions Légales